{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:16:57Z","timestamp":1760548617252,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11174376","31470822","SRFDP 20135503130002"],"award-info":[{"award-number":["11174376","31470822","SRFDP 20135503130002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ejpb.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T13:02:48Z","timestamp":1423314168000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound"],"prefix":"10.1016","volume":"91","author":[{"given":"Tinghe","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haining","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2015.02.003_b0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/GRF.0b013e31824b45da","article-title":"First-line chemotherapy in epithelial ovarian cancer","volume":"55","author":"Bookman","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-540-46091-6_6","article-title":"Resistance to chemotherapy in ovarian carcinoma","volume":"176","author":"Lage","year":"2007","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ejpb.2015.02.003_b0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-1-60761-416-6_19","article-title":"Immunosuppressors as multidrug resistance reversal agents","volume":"59","author":"Morjani","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancers: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2015.02.003_b0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ejpb.2015.02.003_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/153303460600500107","article-title":"Ultrasound: a chemotherapy sensitizer","volume":"6","author":"Yu","year":"2006","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ejpb.2015.02.003_b0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2012.12.007","article-title":"In vivo monitoring of liposomal release in tumours following ultrasound stimulation","volume":"84","author":"Evjen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.02.003_b0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpb.2014.04.011","article-title":"A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles","volume":"88","author":"Huang","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.02.003_b0045","doi-asserted-by":"crossref","first-page":"537260","DOI":"10.1155\/2014\/537260","article-title":"Extracorporeal ultrasound-guided high intensity focused ultrasound: implications from the present clinical trials","volume":"2014","author":"Yu","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejpb.2015.02.003_b0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1245876","article-title":"The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers","volume":"33","author":"He","year":"2012","journal-title":"Ultraschall Med."},{"key":"10.1016\/j.ejpb.2015.02.003_b0055","first-page":"5931","article-title":"Ultrasound enhanced drug toxicity of Chinese hamster ovary cells in vitro","volume":"49","author":"Saad","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2015.02.003_b0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ultras.2009.08.010","article-title":"Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells","volume":"50","author":"Bernard","year":"2010","journal-title":"Ultrasonics"},{"key":"10.1016\/j.ejpb.2015.02.003_b0065","first-page":"680","article-title":"Establishment of human ovarian cancer cisplatin resistant cell line COC1\/DDP and its mechanism of resistance","volume":"76","author":"Zhou","year":"1996","journal-title":"Natl. Med. J. China"},{"key":"10.1016\/j.ejpb.2015.02.003_b0070","first-page":"233","article-title":"Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization","volume":"18","author":"Shenhua","year":"1999","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2015.02.003_b0075","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/bjc.1998.383","article-title":"High-dose cyclosporin with etoposide-toxicity and pharmacokinetic interaction in children with solid tumours","volume":"77","author":"Bisognol","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2015.02.003_b0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0090-8258(92)90070-Y","article-title":"The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin","volume":"47","author":"Mutch","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0085","doi-asserted-by":"crossref","first-page":"s14","DOI":"10.1055\/s-0028-1110020","article-title":"Sonochemotherapy inhibits the adhesion, migration and invasion of human ovarian cancer cells with highly metastatic potential","volume":"32","author":"Zhou","year":"2011","journal-title":"Ultrascall Med."},{"key":"10.1016\/j.ejpb.2015.02.003_b0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/09553002.2014.922721","article-title":"Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay","volume":"90","author":"He","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ultsonch.2003.07.002","article-title":"Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure","volume":"11","author":"Yu","year":"2004","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.ejpb.2015.02.003_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejpb.2015.02.003_b0105","first-page":"146","article-title":"About the evaluation of drug combination","volume":"25","author":"Jin","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejpb.2015.02.003_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejpb.2015.02.003_b0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1537-2995.2008.01942.x","article-title":"Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days","volume":"49","author":"Albanyan","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.ejpb.2015.02.003_b0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bcp.2011.06.015","article-title":"Autophagy as a mediator of chemotherapy-induced cell death in cancer","volume":"82","author":"Notte","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0125","first-page":"3677","article-title":"Role of the Na+, K+-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum (II) in human ovarian carcinoma cells","volume":"51","author":"Andrews","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2015.02.003_b0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0003-2697(84)90556-6","article-title":"A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate","volume":"143","author":"Andrews","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2015.02.003_b0135","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","article-title":"Glutathione S-transferases","volume":"249","author":"Habig","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2015.02.003_b0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2015.02.003_b0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00685625","article-title":"Pharmacokinetics and tissue distribution of cisplatin in nude mice. Platinum levels and cisplatin-DNA adducts","volume":"37","author":"Johnsson","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0150","first-page":"3824","article-title":"Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay","volume":"47","author":"Fingert","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2015.02.003_b0155","first-page":"11","article-title":"Establishment of a mouse subrenal capsular animal model for cisplatin-resistant human ovarian carcinoma cells and its clinical significance","volume":"10","author":"Yu","year":"2001","journal-title":"Prog. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.ejpb.2015.02.003_b0160","first-page":"32","article-title":"An orthotopic ovarian carcinoma model with metastasis in nude mice","volume":"28","author":"Zhang","year":"2010","journal-title":"Sci. Technol. Rev."},{"key":"10.1016\/j.ejpb.2015.02.003_b0165","first-page":"1722","article-title":"Propofol inhibits invasion and enhances paclitaxel induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug","volume":"17","author":"Wang","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejpb.2015.02.003_b0170","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/mp2001846","article-title":"Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin","volume":"8","author":"Yu","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2015.02.003_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity","volume":"7","author":"Cepeda","year":"2007","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.ejpb.2015.02.003_b0180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ijgc-00009577-200505000-00008","article-title":"Ultrastructure alterations in adriamycin-resistant and cisplatin-resistant human ovarian cancer cell lines exposure to nonlethal ultrasound","volume":"15","author":"Yu","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejpb.2015.02.003_b0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.critrevonc.2004.12.010","article-title":"Immunosuppressors and reversion of multidrug-resistance","volume":"56","author":"Aouali","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0190","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1124\/mol.112.079129","article-title":"Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation","volume":"82","author":"Xia","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.02.003_b0195","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bcp.2011.11.016","article-title":"The role of glutathione in brain tumor drug resistance","volume":"83","author":"Backos","year":"2012","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:30:12Z","timestamp":1760545812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641115000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":39,"alternative-id":["S0939641115000508"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.02.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}